|
1
|
Saito I, Azuma K, Kakikawa T, Oshima N,
Hanson ME and Tershakovec AM: A randomized, double-blind,
placebo-controlled study of the effect of ezetimibe on glucose
metabolism in subjects with type 2 diabetes mellitus and
hypercholesterolemia. Lipids Health Dis. 14:402015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Koloverou E, Panagiotakos DB, Pitsavos C,
Chrysohoou C, Georgousopoulou EN, Laskaris A and Stefanadis C:
ATTICA Study group: The evaluation of inflammatory and oxidative
stress biomarkers on coffee-diabetes association: Results from the
10-year follow-up of the ATTICA Study (2002–2012). Eur J Clin Nutr.
69:1220–1225. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lu HJ, Tzeng TF, Liou SS, Da Lin S, Wu MC
and Liu IM: Ruscogenin ameliorates diabetic nephropathy by
itsanti-inflammatory and anti-fibrotic effects in
streptozotocin-induced diabetic rat. BMC Complement Altern Med.
14:1102014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Miyamoto S, Shikata K, Miyasaka K, Okada
S, Sasaki M, Kodera R, Hirota D, Kajitani N, Takatsuka T, Kataoka
HU, et al: Cholecystokinin plays a novel protective role in
diabetic kidney through anti-inflammatory actions on macrophage:
Anti-inflammatory effect of cholecystokinin. Diabetes. 61:897–907.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Saiki S, Sasazawa Y, Imamichi Y, Kawajiri
S, Fujimaki T, Tanida I, Kobayashi H, Sato F, Sato S, Ishikawa K,
et al: Caffeine induces apoptosis by enhancement of autophagy via
PI3K/Akt/mTOR/p70S6K inhibition. Autophagy. 7:176–187. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ribback S, Cigliano A, Kroeger N, Pilo MG,
Terracciano L, Burchardt M, Bannasch P, Calvisi DF and Dombrowski
F: PI3K/AKT/mTOR pathway plays a major pathogenetic role in
glycogen accumulation and tumor development in renal distal tubules
of rats and men. Oncotarget. 6:13036–13048. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang C, Lin MZ, Cheng D, Braet F, Pollock
CA and Chen XM: KCa3.1 mediates dysfunction of tubular autophagy in
diabetic kidneys via PI3k/Akt/mTOR signaling pathways. Sci Rep.
6:238842016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu H, Mi S, Li Z, Hua F and Hu ZW:
Interleukin 17A inhibits autophagy through activation of PIK3CA to
interrupt the GSK3B-mediated degradation of BCL2 in lung epithelial
cells. Autophagy. 9:730–742. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Qiao G, Le Y, Li J, Wang L and Shen F:
Glycogen synthase kinase-3β is associated with the prognosis of
hepatocellular carcinoma and may mediate the influence of type 2
diabetes mellitus on hepatocellular carcinoma. PLoS One.
9:e1056242014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lee YJ and Han HJ: Troglitazone
ameliorates high glucose-induced EMT and dysfunction of SGLTs
through PI3K/Akt, GSK-3β, Snail1 and β-catenin in renal proximal
tubule cells. Am J Physiol Renal Physiol. 298:F1263–F1275. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li H, Yang T, Zhou H, Du J, Zhu B and Sun
Z: Emodin Combined with nanosilver inhibited sepsis by
anti-inflammatory protection. Front Pharmacol. 7:5362017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zeng YQ, Dai Z, Lu F, Lu Z, Liu X, Chen C,
Qu P, Li D, Hua Z, Qu Y and Zou C: Emodin via colonic irrigation
modulates gut microbiota and reduces uremic toxins in rats with
chronic kidney disease. Oncotarget. 7:17468–17478. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang YQ, Huang GR, Wu MH, Tang HY, Huang
ZS, Zhou XH, Yu WQ, Su JW, Mo XQ, Chen BP, et al: Inhibitory
effects of emodin, baicalin, schizandrin and berberine on hefA
gene: Treatment of Helicobacter pylori-induced multidrug
resistance. World J Gastroenterol. 21:4225–4231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhu T, Zhang W, Feng SJ and Yu HP: Emodin
suppresses LPS-induced inflammation in RAW264.7 cells through a
PPARγ-dependent pathway. Int Immunopharmacol. 34:16–24. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen GL, Zhang JJ, Kao X, Wei LW and Liu
ZY: Emodin ameliorates lipopolysaccharides-induced corneal
inflammation in rats. Int J Ophthalmol. 8:665–669. 2015.PubMed/NCBI
|
|
16
|
Li F, Lei T, Xie K, Wu X, Tang C, Jiang M,
Liu J, Luo E and Shen G: Effects of extremely low frequency pulsed
magnetic fields on diabetic nephropathy in streptozotocin-treated
rats. Biomed Eng Online. 15:82016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Duran-Salgado MB and Rubio-Guerra AF:
Diabetic nephropathy and inflammation. World J Diabetes. 5:393–398.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang JJ, Zhang SX, Mott R, Chen Y, Knapp
RR, Cao W and Ma JX: Anti-inflammatory effects of pigment
epithelium-derived factor in diabetic nephropathy. Am J Physiol
Renal Physiol. 294:F1166–F1173. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Baban B, Liu JY and Mozaffari MS:
Endoplasmic reticulum stress response and inflammatory cytokines in
type 2 diabetic nephropathy: Role of indoleamine 2,3-dioxygenase
and programmed death-1. Exp Mol Pathol. 94:343–351. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bhattacharya S, Manna P, Gachhui R and Sil
PC: D-saccharic acid 1,4-lactone protects diabetic rat kidney by
ameliorating hyperglycemia-mediated oxidative stress and renal
inflammatory cytokines via NF-κB and PKC signaling. Toxicol Appl
Pharmacol. 267:16–29. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Yang T, Liu F, Li H, Guo Y, Yang
H, Xu J, Song J, Zhu Z and Liu D: Inflammatory factor-specific
sumoylation regulates NF-κB signalling in glomerular cells from
diabetic rats. Inflamm Res. 63:23–31. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xue WH, Shi XQ, Liang SH, Zhou L, Liu KF
and Zhao J: Emodin attenuates cigarette smoke induced lung injury
in a mouse model via suppression of reactive oxygen species
production. J Biochem Mol Toxicol. 29:526–532. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jain SK, Croad JL, Velusamy T, Rains JL
and Bull R: Chromium dinicocysteinate supplementation can lower
blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated
by elevated blood vitamin C and adiponectin and inhibition of
NFkappaB, Akt, and Glut-2 in livers of zucker diabetic fatty rats.
Mol Nutr Food Res. 54:1371–1380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Su X, Chen X, Liu L, Chang X, Yu X and Sun
K: Intracellular adhesion molecule-1 K469E gene polymorphism and
risk of diabetic microvascular complications: A meta-analysis. PLoS
One. 8:e699402013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang LQ, Ni WJ, Cai M, Ding HH, Liu S and
Zhang ST: The renoprotective effects of berberine and its potential
impact on the expression of beta-arrestins and ICAM-1/VCAM-1 in
streptozocin induced-diabetic nephropathy rats. J Diabetes.
8:693–700. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dong M, Yang G, Liu H, Liu X, Lin S, Sun D
and Wang Y: Aged black garlic extract inhibits HT29 colon cancer
cell growth via the PI3K/Akt signaling pathway. Biomed Rep.
2:250–254. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wang XM, Yao M, Liu SX, Hao J, Liu QJ and
Gao F: Interplay between the Notch and PI3K/Akt pathways in high
glucose-induced podocyte apoptosis. Am J Physiol Renal Physiol.
306:F205–F213. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Park SJ, Jin ML, An HK, Kim KS, Ko MJ, Kim
CM, Choi YW and Lee YC: Emodin induces neurite outgrowth through
PI3K/Akt/GSK-3beta-mediated signaling pathways in Neuro2a cells.
Neurosci Lett. 588:101–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mariappan MM, Prasad S, D'Silva K, Cedillo
E, Sataranatarajan K, Barnes JL, Choudhury GG and Kasinath BS:
Activation of glycogen synthase kinase 3β ameliorates
diabetes-induced kidney injury. J Biol Chem. 289:35363–35375. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang G, Tang X, Gao P, Guo F, Liu H, Zhao
Z, Chen Q, Jiang T, Zhang N and Li H: Sulforaphane attenuation of
experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2
signaling pathway. J Nutr Biochem. 26:596–606. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Singh LP, Jiang Y and Cheng DW: Proteomic
identification of 14-3-3zeta as an adapter for IGF-1 and
Akt/GSK-3beta signaling and survival of renal mesangial cells. Int
J Biol Sci. 3:27–39. 2007. View Article : Google Scholar
|
|
32
|
Wu Z, Chen Q, Ke D, Li G and Deng W:
Emodin protects against diabetic cardiomyopathy by regulating the
AKT/GSK-3beta signaling pathway in the rat model. Molecules.
19:14782–14793. 2014. View Article : Google Scholar : PubMed/NCBI
|
